News: Pfizer Inc (PFE)

PFE on New York Consolidated

30.40USD
19 Sep 2014
Price Change (% chg)

$-0.18 (-0.59%)
Prev Close
$30.58
Open
$30.76
Day's High
$30.84
Day's Low
$30.26
Volume
35,022,166
Avg. Vol
22,986,182
52-wk High
$32.96
52-wk Low
$27.87

Search Stocks
Select another date:

Fri, Sep 12 2014

Photo

Pfizer, Ranbaxy win dismissal of lawsuit over generic Lipitor

(Reuters - Pfizer Inc and India's Ranbaxy Laboratories Ltd on Friday won dismissal of a U.S. antitrust lawsuit accusing them of conspiring to delay sales of generic versions of the best-selling cholesterol drug Lipitor.

UPDATE 1-Pfizer, Ranbaxy win dismissal of lawsuit over generic Lipitor

Sept 12 (Reuters - Pfizer Inc and India's Ranbaxy Laboratories Ltd on Friday won dismissal of a U.S. antitrust lawsuit accusing them of conspiring to delay sales of generic versions of the best-selling cholesterol drug Lipitor.

UPDATE 1-Pfizer, Ranbaxy win dismissal of lawsuit over generic Lipitor

Sept 12 - Pfizer Inc and India's Ranbaxy Laboratories Ltd on Friday won dismissal of an antitrust lawsuit accusing them of conspiring to delay sales of generic versions of the cholesterol drug Lipitor, the best-selling drug in history.

BRIEF-Pfizer, Ranbaxy win dismissal of lawsuit by "direct purchaser" plaintiffs over generic Lipitor

Sept 12 - * U.S. judges grants Pfizer Inc Ranbaxy Laboratories Ltd

UPDATE 2-SAC's Martoma gets 9 years prison for insider trading

(Adds details from court hearing, comment from Martoma spokesman)

Zoetis granted conditional license by USDA for PEDv vaccine

CHICAGO - Zoetis Inc has received a conditional license from the U.S. Department of Agriculture for its vaccine against a deadly piglet virus and will begin selling it this month in the United States, the company said on Wednesday.

Weaker healthcare stocks weigh on European equities

* Bid target AstraZeneca falls; CEO says "back to normal"

European equities dip as healthcare stocks weaken

* Bid target AstraZeneca falls; CEO says "back to normal"

Early data suggest Sanofi, Regeneron drug may halve heart risk

* Good news for new PCSK9 drug class but needs confirmation

FTSE inches higher, Tesco slumps after profit warning

LONDON, Aug 29 - Britain's top share index ended slightly higher on Friday, with stronger pharmaceutical stocks on renewed merger and acquisition talks outpacing a sharp decline in retail stocks after another profit warning by Tesco .

Select another date:

Press Releases

Search Stocks